Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein Cares Foundation announces the appointment of
Henry Schein (Nasdaq: HSIC) announced an agreement to acquire Condor Dental Research Company SA, enhancing its presence in the Swiss dental distribution market. Condor, established in 1978, reported $18 million in sales in 2021, primarily from dental consumables. The acquisition is expected to be neutral to diluted earnings per share in 2022 and accretive thereafter. This strategic move aligns with Henry Schein's commitment to expand its offerings and improve services in the dental sector across Europe.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, presented at the William Blair Emerging Technologies in Dental Care Virtual Investor Conference on May 17, 2022. A replay will be accessible on their investor presentations webpage starting May 19, 2022, for up to two weeks. The company reported sales of $12.4 billion in 2021, with a 12.5% compound annual growth rate since going public in 1995. Henry Schein serves over 1 million customers globally through a network of nearly 22,000 Team Schein Members.
Henry Schein, the largest provider of healthcare solutions for dental and medical practitioners, announced its participation in two upcoming investor conferences in June 2022. The events include the Stifel 2022 Annual Dental & Veterinary Conference on June 1 and the Jefferies 2022 Healthcare Conference on June 9. Live webcasts of the presentations will be available on Henry Schein's investor relations website. The company highlights its extensive global network, serving over 1 million customers with more than 300 solutions aimed at enhancing operational success and clinical outcomes.
Henry Schein has appointed Dirk Benson as Vice President and Chief Commercial Officer of its North America Distribution Group. His role will focus on driving the 'One Distribution' strategy to enhance efficiency and customer experience. Nancy Lanni has been named Vice President and General Manager of the new Strategic Account Management Team. Both executives bring extensive expertise from the health care industry and will play a key role in implementing the company's 2022-2024 BOLD+1 Strategic Plan.
Henry Schein (NASDAQ: HSIC) announced a donation of
Henry Schein, Inc. (Nasdaq: HSIC), a leading health care solutions provider, will present at the UBS Global Healthcare Conference on May 24, 2022, at 2:00 p.m. Eastern time. The presentation will be available via live webcast on their website, with a replay accessible afterward.
Henry Schein serves over 1 million customers globally with a wide range of solutions, achieving $12.4 billion in sales in 2021. The company operates a centralized distribution network and provides more than 120,000 branded products.
Henry Schein reported record first-quarter 2022 net sales of $3.2 billion, an 8.7% increase from Q1 2021. The GAAP diluted EPS rose to $1.30, up from $1.16 the previous year. The company affirms its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91, projecting growth of 7% to 10% over 2021. Growth was driven by strong sales in both the dental and medical segments, particularly in equipment and technology sales. However, sales of COVID-19 related products are expected to decline, impacting overall sales guidance.
Henry Schein (NASDAQ: HSIC) supports the Carry The Load Memorial May campaign, honoring military, veterans, first responders, and their families. The initiative, running from April 28, 2022, involves events such as the Dallas Memorial March and other rallies across the U.S. Team Schein Members will participate in walks, fundraise, and attend educational events. This partnership aligns with Henry Schein's commitment to veterans' health and accessibility to dental care, showcasing its corporate social responsibility through meaningful community engagement.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?
Does Henry Schein have any recent achievements?
